ArticleKidney international2013
The road from AKI to CKD: the role of endothelin.
Article in Kidney international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 25 citations in OpenAlex.
- Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19.Pulmonary pharmacology & therapeutics · 2021Review
- Early activation of fibroblasts is required for kidney repair and regeneration after injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019Article
- Tenascin-C protects against acute kidney injury by recruiting Wnt ligands.Kidney international · 2019Article
- Short-term dexamethasone treatment transiently, but not permanently, attenuates fibrosis after acute-to-chronic kidney injury.BMC nephrology · 2018Article
- Article
- Fibroblast-SpecificJournal of the American Society of Nephrology : JASN · 2018Article
- Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies.Biochimica et biophysica acta. Molecular basis of disease · 2017Review
- Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545.Oncotarget · 2017Article
- G Protein-Coupled Receptor-G-Protein βγ-Subunit Signaling Mediates Renal Dysfunction and Fibrosis in Heart Failure.Journal of the American Society of Nephrology : JASN · 2017Article
- Lack of an apparent role for endothelin-1 in the prolonged reduction in renal perfusion following severe unilateral ischemia-reperfusion injury in the mouse.Physiological reports · 2016Article
- On the occasion of world kidney day 2016; work together to better protect the kidney.Journal of nephropathology · 2016Review
- Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice.PloS one · 2016Article
- Long-term sequelae from acute kidney injury: potential mechanisms for the observed poor renal outcomes.Critical care (London, England) · 2015Review
- Chronic kidney disease and aging: The theme of world kidney day in 2014; nephrologist will become the professional geriatrist.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014Article
- World Kidney Day 2014: increasing awareness of chronic kidney disease and aging.Journal of renal injury prevention · 2014Article
- World Kidney Day 2014; Chronic Kidney Disease and Aging: A Global Health Alert.Iranian journal of public health · 2014Article
- The awareness of chronic kidney disease and aging; the focus of world kidney day in 2014.Journal of nephropharmacology · 2014Article
Corrections and comments
- Comment on
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The incidence of acute kidney injury (AKI) is increasing. It is now widely accepted that patients surviving an episode of AKI have a significant risk of progression to chronic kidney disease (CKD) and even end-stage renal failure. Zager and colleagues describe the role of endothelin-1 (ET-1) in the progression of AKI to CKD and provide a basis for the potential use of ET receptor antagonists as a therapeutic strategy in AKI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.